Toxoplasmosis

被引:41
作者
Beazley, DM [1 ]
Egerman, RS [1 ]
机构
[1] Univ Tennessee, Dept Obstet & Gynecol, Div Maternal Fetal Med, Memphis, TN 38103 USA
关键词
D O I
10.1016/S0146-0005(98)80022-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Toxoplasmosis is caused by the protozoan organism, Toxoplasma gondii. Infection with this organism primarily results from contact with infected cats and from ingestion of improperly cooked meat. Most adults with toxoplasmosis are asymptomatic. When symptoms are present, they typically resemble a mononucleosis or flulike illness. The diagnosis of toxoplasmosis in the pregnant adult is best made using serological techniques to detect IgM antibody and to document significant changes in the IgG antibody titer. Congenital toxoplasmosis usually occurs as a result of primary maternal infection. The most useful tests for confirmation of fetal infection are ultrasound examination, cordocentesis for detection of IgM-specific antibody, and amniocentesis for detection of toxoplasma DNA in amniotic fluid. Congenital toxoplasmosis can be treated with reasonable success by administration of antibiotics (spiramycin, sulfadiazine, and pyrimethamine) to the mother. In an effort to prevent acquisition of infection, pregnant women should be counseled to avoid contact with cat litter and improperly cooked beef, pork, or lamb.
引用
收藏
页码:332 / 338
页数:7
相关论文
共 42 条
[1]   EVALUATING THE SENSITIVITY AND PREDICTIVE VALUE OF TESTS OF RECENT INFECTION - TOXOPLASMOSIS IN PREGNANCY [J].
ADES, AE .
EPIDEMIOLOGY AND INFECTION, 1991, 107 (03) :527-535
[2]   METHODS FOR ESTIMATING THE INCIDENCE OF PRIMARY INFECTION IN PREGNANCY - A REAPPRAISAL OF TOXOPLASMOSIS AND CYTOMEGALOVIRUS DATA [J].
ADES, AE .
EPIDEMIOLOGY AND INFECTION, 1992, 108 (02) :367-375
[3]   Toxoplasmosis and parvovirus B19 [J].
Alger, LS .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (01) :55-+
[4]   TERMINATION OF PREGNANCY FOR MATERNAL TOXOPLASMOSIS [J].
BERREBI, A ;
KOBUCH, WE ;
BESSIERES, MH ;
BLOOM, MC ;
ROLLAND, M ;
SARRAMON, MF ;
ROQUES, C ;
FOURNIE, A .
LANCET, 1994, 344 (8914) :36-39
[5]   IGA ANTIBODY-RESPONSE DURING ACQUIRED AND CONGENITAL TOXOPLASMOSIS [J].
BESSIERES, MH ;
ROQUES, C ;
BERREBI, A ;
BARRE, V ;
CAZAUX, M ;
SEGUELA, JP .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (07) :605-608
[6]   Outbreak of toxoplasmosis associated with municipal drinking water [J].
Bowie, WR ;
King, AS ;
Werker, DH ;
IsaacRenton, JL ;
Bell, A ;
Eng, SB ;
Marion, SA .
LANCET, 1997, 350 (9072) :173-177
[7]  
Boyer K M, 1996, Adv Pediatr Infect Dis, V11, P449
[8]  
CAZANARE J, 1992, PRENATAL DIAG, V12, P1190
[9]   Congenital toxoplasmosis with hydrocephalus: Prenatal diagnosis and developmental outcome in a treated child [J].
Cotty, F ;
Carpentier, MA ;
Descamps, P ;
Perrotin, F ;
RichardLenoble, D .
ARCHIVES DE PEDIATRIE, 1997, 4 (03) :247-250
[10]   INUTERO TREATMENT OF TOXOPLASMIC FETOPATHY WITH THE COMBINATION PYRIMETHAMINE-SULFADIAZINE [J].
COUVREUR, J ;
THULLIEZ, P ;
DAFFOS, F ;
AUFRANT, C ;
BOMPARD, Y ;
GESQUIERE, A ;
DESMONTS, G .
FETAL DIAGNOSIS AND THERAPY, 1993, 8 (01) :45-50